ExonanoRNA, LLC, a spin-off company from The Ohio State University, is seeking an executive level consultant for preclinical and early clinical development. We are open to converting this position to a full-time executive position for candidates who share the same passion about our technology.

ExonanoRNA is focused on RNA nanoparticles which is a type of nanoparticles by using RNA as scaffolds for chemical drug delivery or small RNA delivery. RNA nanoparticles show a unique pharmacological profile and excellent safety profiles compared to other nanoparticles or bioconjugates. It can be well designed to reduce immune system stimulation to undetectable levels and allows repetitive dosing regimen. The optimal size of RNA nanoparticles ensures its accumulation in the tumor but fast clearance in other tissues. Following the success of the RNA vaccine, we truly believe the value of RNA in treating human diseases. We are determined to move RNA nanoparticles into clinics to address unmet medical needs.

Since the inception of ExonanoRNA, LLC 2017, we’ve built a mature production line for RNA nanoparticles. Our customers are spreading across 35+ high profile research organizations or pharmaceutical companies from the US, such as Mayo Clinic, NIH, Duke University, City of Hope, United Therapeutics, Vertex etc. Our current focus is to move several drug candidates into IND for treating metastatic cancers. We are looking forward to a passionate senior leader guiding us to move these innovative drugs onto bedside.

Primary Responsibilities include:

This position will provide consulting services for platform building, strategic planning, portfolio management and operational oversight of pre-clinical development programs.

• Supervise platform building and strategic planning
• Support decision making for portfolio management
• Help building up relationship with investors and big pharma
• Support fundraising preparation
• Supervise IND experiment design, CMC production building and IND filing

Qualifications:

• Degree in scientific/life-sciences field. MD, Pharm.D., or Ph.D. is required
• Minimum of 25 years of experience in research with at least 15 or more years of drug development experience is required
• Executive level experience in biotech or pharma companies is preferred
• 10 years Oncology therapeutic area experience are preferred
• Prior bioconjugates or nanotechnology based drug delivery experience a plus
• Experience with small RNA for cancer treatment a plus
• Passionate about novel therapeutic modality development

ExonanoRNA, LLC is an equal-opportunity employer.